4
Changes in Ownership
Dianthus Therapeutics, Inc. /DE/ Filed Acc 0000950170-25-114293
CFO & CBO sold 20,000 shares at $35.00 ($700,000)
- CFO & CBO acquired 20,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Savitz Ryan CFO & CBO | 2025-09-09 | Option exercise 10b5-1 | +20,000 | $8.44 | $168,800 | 20,000 | D |
| Savitz Ryan CFO & CBO | 2025-09-09 | Sale 10b5-1 | −20,000 | $35.00 | $700,000 | 0 | D |
| Derivatives | |||||||
| Savitz Ryan CFO & CBO | 2025-09-09 | Option exercise · Stock Option (Right to Buy) 10b5-1 | +20,000 | 104,766 | D | ||
| Open-market sales · 20,000 sh · avg $35.00 · $700,000 | |||||||
Loading xslF345X05/ownership.xml…